Gout sufferers could ditch doctor visits with new Self-Monitoring app

NCT ID NCT05507723

Recruiting now Disease control Sponsor: University of Edinburgh Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two ways of managing gout: a supported self-management approach where patients monitor their own urate levels with a finger-prick test and adjust medication via a smartphone app, versus usual care where a doctor manages treatment. The goal is to see if the self-monitoring method reduces gout flares over two years. The trial will enroll 125 adults with gout who have had at least one flare in the past year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: urate-lowering medication (e.g., allopurinol) adjusted via self-monitoring
What this could lead to: If successful, this approach could give gout patients a practical way to manage their condition at home, leading to fewer painful flares and better long-term control.
What could go wrong: This is a relatively small trial (125 people) and relies on patients consistently using the app and self-testing, which may not work for everyone. The benefits seen in earlier short-term studies may not hold over two years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GOUT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gout

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GOUT

Contacts and locations

Locations

NHS Lothian
RECRUITING

Edinburgh, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.